Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 5, 2024
Product Development

LNP innovation: tissue specificity, aided by AI

How LNP companies delivering nucleic acids are cracking the tissue tropism problem, and finding freedom to operate
BioCentury | Aug 13, 2021
Translation in Brief

AAV COVID-19 vaccine provides durable protection in monkeys

Plus mAb-based contraception, metabolites for autism and more
BioCentury | Mar 26, 2020
Emerging Company Profile

ReCode: merging RNA therapies and organ-specific delivery for respiratory diseases

ReCode is combining RNA therapies with an organ-specific lipid nanoparticle delivery system
BioCentury | Apr 23, 2009
Distillery Therapeutics

Indication: Pulmonary disease

Items per page:
1 - 4 of 4